Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Latest news from Datamonitor

October 13, 2008 Sales and Marketing HIV

Battle for HIV drug market share getting fiercerThe HIV market, worth $9.3 billion in 2007, is expected to grow to …
News

Novartis pursues pulmonary hypertension indication for Glivec

October 10, 2008 Sales and Marketing

Novartis says new data on Glivec shows it has potential to treat a life-threatening heart condition, despite failing to meet …
News

A postcard from … Slovakia

October 10, 2008 Research and Development, Sales and Marketing Europe, Slovakia, hc

Feature

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008 Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …
News

GlycArt’s new cancer candidate to be developed with Roche

October 9, 2008 Research and Development, Sales and Marketing GlycArt, Roche

Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …
News

Norgine quits ABPI and denounces big pharma bias

October 6, 2008 Sales and Marketing ABPI, Norgine

News

Latest news from Datamonitor

October 6, 2008 Sales and Marketing OTC

Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? The growing cost of developing …
News

Emerging confidence

October 2, 2008 Research and Development, Sales and Marketing emerging markets, evidence-based medicine

 The wisdom that emerging markets are vital to the pharmaceutical and biotechnology industry’s future has become a lot more conventional …
Feature

Osteoporosis drug Aclasta approved for use in men

October 2, 2008 Sales and Marketing Novartis, aclasta, osteoporosis

Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …
News

Long-acting Zyprexa gets green light

October 2, 2008 Sales and Marketing lilly, psych

Lilly's Zypadhera has been recommended in Europe for use in stabilising schizophrenic patients who are already receiving treatment. The European …
News

Spiriva partners defend drug’s safety

October 2, 2008 Sales and Marketing Boehringer, COPD, Spiriva, resp

Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …
News

Weak currency helps UK pharmaceutical industry

October 1, 2008 Manufacturing and Production, Sales and Marketing parallel trade

Pharmaceutical companies operating in the UK are experiencing reduced competition from European parallel importers, thanks to the weakness of the …
News

Overcoming barriers to access

September 30, 2008 Sales and Marketing Europe, UK, market access, strategies

Feature

Latest news from Datamonitor

September 29, 2008 Sales and Marketing par

Is cost containment impacting pharmaceutical innovation?With the cost of healthcare provision spiraling, governments and payers across the seven major markets …
News

Pradaxa approved by NICE

September 26, 2008 Sales and Marketing NICE, Pradaxa, clot, cv

NICE has recommended Boehringer Ingelheim's novel anti-clotting pill Pradaxa, giving it a marketing edge over Bayer's rival treatment Xarelto. Pradaxa …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026